go to main content
18 April 2019

Jakko van Ingen received the ESCMID Young Investigator Award for his groundbreaking work on nontuberculous mycobacterial disease.

During the European Conference on Clinical Microbiology and Infectious Diseases (ECCMID), consultant clinical microbiologist and RIHS scientist Jakko van Ingen received the Young Investigator Award for his groundbreaking work on nontuberculous mycobacterial disease. Jakko has performed landmark studies which showed that pathogenicity of nontuberculous mycobacteria differs strongly by species, that current antibiotic treatment regimens can be optimized by better use of susceptibility testing and that several new and repurposed antibiotics can improve treatment outcomes in nontuberculous mycobacterial disease. For this work, captured in 170 papers in peer-reviewed journals and 10 book chapters, he received this prestigious award. 

Jakko van Ingen is member of theme Infectious diseases and global health.

Related news items

Chronic malaria infections produce more and more infectious gametocytes

28 April 2021 In a recent article in Nature Communications, researchers from the department of Medical Microbiology uncovered intriguing dynamics in the production of the transmission stages of malaria parasites, gametocytes. read more

Invasive fungal infections in influenza and COVID-19

8 July 2020 The Aspergillus fungus is found in the lungs of many COVID patients. A parallel occurs with influenza patients, who often develop a serious fungal infection. Although such a serious fungal infection seems to occur less frequently in COVID-patients, alertness remains necessary, read more

Early symptoms in Radboudumc healthcare workers who were tested for SARS-CoV-2

12 May 2020 In Eurosurveillance RIHS researcher Alma Tostmann and colleagues from the Radboudumc COVID-19 Team describe that general symptoms like fever, headache, general malaise and muscle ache were associated with a positive SARS-CoV-2 test. Respiratory symptoms however, were not predictive for SARS-CoV-2. read more

Dealing with COVID-19 in low- and middle-income countries

26 March 2020 RIHS researcher Joost Hopman believes that low-and middle-income countries should intensify their preparedness for a possible COVID-19 outbreak. This was the core message of an opinion article that he wrote at the request of the medical journal JAMA. read more

ERC Consolidator Grant for Bousema and Sechopoulos

12 December 2019 Teun Bousema and Ioannis Sechopoulos each receive an ERC Consolidator Grant of around two million euros. This European research subsidy will enable them to carry out research for the next five years. read more

Two RIHS researchers in top 1 percent by citations

28 November 2019 Bart-Jan Kullberg and Jacques Meis, made it to this year’s list of highly cited researchers. Researchers in this list are selected for their exceptional research performance and are regarded to have had a major impact on fellow scientists. read more